Regulators scramble to tighten loopholes after heparin debacle.
Jia
Hepeng
H
D002681:China; D017277:Drug Approval / Q000458:organization & administration; D004340:Drug Contamination / Q000331:legislation & jurisprudence* / Q000517:prevention & control*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards*; D033161:Government Regulation; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
D006493:Heparin